Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Cancer. 2010 Mar 1;116(5):1305–1314. doi: 10.1002/cncr.24884

Table 2.

Hazard ratios (±95%CI) between presence or absence of variable of interest Bolded values for comparisons have p<0.05

Variable TACE (95% CI) Y90 (95% CI)
Demographics
 Males vs. Females 1.29(1.07–1.55) 1.63(0.99–2.69)
 Heavy Alcohol 1.32(1.08–1.63) 1.72(0.98–3.01)
 Heavy Tobacco 1.20(0.90–1.61) 2.47(1.17–5.25)
Concomitant Liver Disease
 HBV only 0.77(0.61–0.98) 2.75(1.31–5.78)
 HCV only 1.21(0.98–1.57) 1.28(0.76–2.16)
 Cirrhosis (any cause) 1.50(1.25–1.81) 1.96(1.02–3.69)
Tumor Characteristics
 Tumor Size ≥5 cm 1.17(0.90–1.38) 0.78(0.41–1.50)
 Tumor Number ≥5 1.06(0.88–1.3) 1.8(1.01–3.21)
 Portal Vein Thrombosis 1.31(1.11–1.54) 2.13(1.33–3.39)
 Alpha-fetoprotein ≥25 ng/ml 1.56(1.30–1.88) 1.71(1.09–2.70)
Liver Function
 Bilirubin ≥1.5 mg/dL 1.55(1.29–1.86) 2.69(1.44–5.04)
 Albumin <3.5 g/dL 1.48(1.22–1.78) 2.03(1.25–3.31)